Coccidiosis Treatment Market - Forecast(2024 - 2030)

Coccidiosis Treatment Market size is estimated to reach $3.2 billion by 2030, growing at a CAGR of 3.6% during the forecast period 2024-2030. Coccidiosis is an ailment of birds and mammals that essentially influences the intestines, brought about by Coccidia. Coccidiosis treatment involves the natural growth of immunity to coccidiosis which may advance during the application of anticoccidials in the feed. The surging acceptance of exhaustive farming techniques and proliferating demand for meat proteins fuelling meat production in developed countries are set to drive the Coccidiosis Treatment Market. The boost in the government spending on poultry in numerous countries across the world and the rising pervasiveness of ailments like coccidiosis and toxoplasmosis are set to propel the growth of the Coccidiosis Treatment Market. 

One recent advancement in coccidiosis control is a platform technology that can individually vaccinate up to 100,000 chicks per hour against coccidiosis and other diseases. There are several other innovations currently in development that could transform modern coccidiosis outbreaks. Predictive diagnostics can analyze current disease outbreak patterns to draw conclusions about future outbreaks and thus preventing losses.

The report: “Coccidiosis Treatment Market Forecast (2024-2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Coccidiosis Treatment Market.

By Drug Type: Ionophore Drugs, Antibiotic Drugs, Chemical Derivative Drugs.

By Infected Animal Species: Swine, Poultry, Companion Animals, Fish, Cattle.

By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

 

• Geographically, North America Coccidiosis Treatment Market accounted for the highest revenue share in 2023 and it is poised to dominate the market owing to the enormous demand for meat food and related products and the proliferating count of poultry and companion animals together with the growing predominance of coccidian ailments including toxoplasmosis in the North American region.

• Coccidiosis Treatment Market growth is being driven by the increasing predominance of coccidian diseases amidst poultry and companion animals including toxoplasmosis and the expanding population and per capita intake of meat. 

• However, the rising food safety concerns and augmenting meat prices worldwide are some of the major factors hampering the growth of Coccidiosis Treatment Market. 

 

The Ionophore Drugs Segment held the largest market share in 2023. This growth is owing to the surging application of ionophore drugs for the avoidance of coccidiosis owing to the broad-spectrum activity against most of the pathogenic species causing coccidian diseases and the dearth of development of medication resistance. A large-scale pen study in Europe found the birds treated with Narasin experienced a 3.3% increase in average daily feed intake, compared to those given salinomycin, and their final body weight was also 150g higher. As a result, broiler producers are being encouraged to use a narasin-based ionophore coccidiosis control program throughout the production cycle. The soaring inclusion of ionophore drugs in starter and grower feeds is further propelling the growth of the Ionophore Drugs segment. 

 

The Poultry segment held the largest market share in 2023. Coccidiosis causes diarrhea, weight loss and decreased production in poultry and can be fatal. Signs of coccidiosis range from decreased growth rate to many sick birds, with severe diarrhea and high mortality. Decreased feed and water consumption, weight loss, and decreased egg production, may accompany outbreaks. The proliferating awareness regarding different treatment alternatives pertaining to coccidiosis is further propelling the growth of this segment. The industry is aware of the importance of using one or more of the strategies that are available on the market, either anticoccidial drugs or vaccines to control the disease.

 

North America held the largest share with 36% of the Coccidiosis Treatment market in 2023. The growth of this region is owing to the increasing predominance of coccidiosis in food-producing animals and companion animals. As per the U.S. Department of Agriculture, coccidiosis costs the U.S. poultry industry in excess of $300 million annually. According to a survey of broiler veterinarians in the United States, coccidiosis was ranked as the top disease-related issue. A similar survey of the US Association of Veterinarians in Egg Production (AVEP) indicated that coccidiosis was considered the most important disease or condition in replacement layers reared cage-free. The soaring progress in veterinary healthcare is further propelling the growth of the Coccidiosis Treatment Market in the North American region.

 

Coccidiosis is a protozoan disease in poultry for which anticoccidial drugs are available and it is correctable by preventive programs also at the time of the outbreak in the field. It most frequently is visible in chicks three to six weeks of age. The worst cases happen at four to five weeks. There are three principal goals of Anticoccidial drug programs in poultry. They are targeted to generate the maximum growth and feed effectiveness with the least cost and ailment in broilers. The second goal is to establish persistent immunization for lengthier periods of time in layers or breeders. The third goal is to prevent anticoccidial drug resistance in the field and decrease medication costs. The selection of a product or program may rely on the season of the year or other factors which influence exposure to the coccidial population. Frequently, a single product will be utilized from day one to slaughter, or with a withdrawal period of 3–7 days. Nearly all products are authorized for application until slaughter. The application of one product in the starter feed and another in the grower feed for the purpose of avoidance and regulation of coccidiosis is termed a shuttle program in the U.S. and a dual program in additional countries. These programs are mostly utilized for industrial purposes where bigger poultry feed production is operated. The surging applications of anticoccidial drug programs in poultry are therefore fuelling the growth of the Coccidiosis Treatment Market during the forecast period

 

In the poultry industry coccidiosis brings about significant economic loss. According to EW Nutrition, with costs of over $14 billion per year, coccidiosis is one of the most devastating challenges in the poultry industry.  Eimeria species are termed as protozoan parasites to bring about morbidity and demise in poultry. Over 300,000 species of flowering plants have been reported globally. To date, less than 1% of them have been investigated for application against protozoan ailments. A. annua and its component active compound artemisinin have been recorded to possess anticoccidial action. The extract from the bark of the pine tree (Pinus radiata), which is abundant in condensed tannins, was recorded to restrict the life cycle of Coccidia as proved by reduced sporulation of the oocysts of E. tenella, E. maxima, and E. acervuline. Green tea extracts have been demonstrated to considerably restrict the sporulation process of coccidian oocysts. Correspondingly, the selenium and polyphenolic compounds in green tea are thought to be active compounds to inactivate the enzymes accountable for coccidian sporulation. The proliferating applications of herbal antidotes for coccidiosis regulation are therefore driving the growth of the Coccidiosis Treatment Market during the forecast period 2022-2027.

 

 

Coccidia being the simplest parasite consistently adjusts to medications utilized against them. Owing to them, there may be paresis of muscles on the legs of turkey poults. Even with exacting adherence to the dosage, there is a likelihood of poisoning with medications. There could be probable bleeding in the gastrointestinal tract of turkey poultry. Vaccine- and antibiotic-based techniques for curbing coccidiosis have numerous limitations. Consumers and governments are increasingly demanding a decrease in antibiotic application in poultry. In Antibiotic Free (AF) chains, the average mortality rate is 5.5% as reported in 2019, against 3-3.5% in regular production. These issues are thus hampering the growth of the Coccidiosis Treatment Market.

 

 

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the Coccidiosis Treatment Market.

1. dsm-firmenich
2. Vetoquinol SA
3. Zoetis, Inc.
4. Huvepharma
5. Boehringer Ingelheim Vetmedica, Inc.
6. Merck Animal Health
7. HIPRA
8. Elanco 
9. Merial
10. Bayer Animal Health 

     For more Chemicals and Materials Market reports, please click here